$VIVK

Vivakor (VIVK) delays Q2 2026 10-Q but signals higher revenue and lower loss

Vivakor, Inc. (VIVK) said it will file its Q2 2026 Form 10-Q for the period ended June 30, 2026 later than the Aug. 14, 2026 due date for smaller reporting companies, citing delays finalizing financial statements and disclosures. It expects higher total revenues and gross profit, lower operating expenses, and a smaller net loss versus Q2 2025, but cannot assure filing within the five-day Rule 12b-25 extension.

Original reporting
Published Aug 14, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 1:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$VIVK
Neutral
medium confidence
Mentioned
$VIVK
Relevance
6/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$VIVKNeutralMed
01

Why it matters

The key trade driver is the compliance and information-timing risk from the delayed 10-Q, partially offset by management’s expectation of improved operating metrics versus Q2 2025.

02

Market read

This is a company-specific reporting delay with a directional earnings outlook, likely to drive short-term volatility around the extension window.

03

What to watch

Investors may need to monitor whether the company meets the five-day extension and whether the final disclosures materially differ from the preliminary directional expectations.

Relevance 6/10Novelty 6/10Timing: filing deadline missed, extension window for the Q2 2026 10-Q

Background

Vivakor, a smaller reporting company, missed the August 14, 2026 due date for its Q2 2026 Form 10-Q and filed for a Rule 12b-25 extension.

Company-level read

Ticker impact

$VIVKNeutralMedium confidence
Context

Vivakor says it will delay its Q2 2026 Form 10-Q due to incomplete financial statements, while expecting higher revenue and lower loss.

Expected impact

Near-term volatility risk from the late 10-Q, with potential stabilization if investors focus on the guided improvement in revenue and net loss.

Evidence & confidence

The article discloses a concrete regulatory/timing event (10-Q delay under Rule 12b-25) plus management’s expectations for improved quarter results, but provides no numbers or certainty on the extension deadline.

Market effects

Limited direct sector read-through; the main signal is reporting-timeline risk for smaller reporting companies.

None indicated.

None indicated.

Counterpoint

The delay could reflect unresolved accounting or disclosure issues, so the “higher revenue, lower loss” expectations may not be reliable until the 10-Q is filed.

Key entities

  • Vivakor, Inc.

    Subject of the filing delay and the directional outlook for Q2 2026 results.

  • Rule 12b-25

    Provides a limited extension period for filing a delayed Form 10-Q for smaller reporting companies.

Related articles

$VIVKHighAI 8/10

Vivakor expands Cushing crude deal to $420M

Vivakor, Inc. (VIVK) expanded its Cushing crude oil deal to $420M annualized, adding a new contract for 100,000 barrels/month through 2027, expected to generate $90M in annual gross revenue. The deal strengthens its position in North American crude oil trading hubs, leveraging its infrastructure and logistical expertise.

$VIVKMed

Vivakor doubles crude oil platform to $1.5 billion annually

Vivakor Inc. (VIVK) expanded its crude oil marketing business, increasing its annualized activity to $1.5 billion with new long-term programs. The deals add $400 million in value and cover 500,000 barrels per month. CEO James Ballengee highlighted rapid scaling but noted thin gross margins. Shares were up 0.52% in premarket trading. Additionally, Vivakor commenced commissioning at its Remediation Processing Center in Texas, marking a strategic milestone. Shares were down 5.71% in premarket tradi

$MTWOMed

M2i Global signs deal to explore merger with Vivakor

M2i Global Inc (OTC:MTWO) and Vivakor Inc (NASDAQ:VIVK) signed a non-binding agreement to explore combining businesses to strengthen the US critical minerals supply chain. They will negotiate for 30 days on valuation and structure, with Vivakor currently expected to acquire M2i in a stock deal. Talks could proceed, lead to a detailed deal, or end.

$VIVKMed

Vivakor Pursues Critical Minerals Push With M2i Global Merger Talks — BigGo Finance

Vivakor Inc (NASDAQ:VIVK) and M2i Global Inc (OTCQB:MTWO) entered a non-binding agreement to evaluate a potential business combination. The companies announced an initial 30-day negotiation window focused on valuation, deal structure, and leadership. Vivakor would acquire M2i via an equity exchange, subject to due diligence and approvals. Vivakor premarket was $1.295, down 2.63%.

$VIVKMed

Vivakor Targets $2 Billion in Annualized Crude Trading Through VST

Vivakor (Nasdaq: VIVK) said its subsidiary Vivakor Supply & Trading (VST) signed new 12-month sales contracts for WTI crude oil, running Sept. 1, 2026 to Aug. 31, 2027. The company cited nearly $2 billion in annualized commercial activity for its trading business, though it was not presented as a formal updated total. VST’s gross margin is a fraction of contract value.